copyright and Wegovy, two recent advances in the field of weight management, have garnered significant attention for their promising results. These medications, both belonging to a class called GLP-1 receptor agonists, work by stimulating the body's natural processes to suppress appetite and improve insulin sensitivity. Early clinical trials have